Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 23 | 2024 | 101 | 6.080 |
Why?
|
| Air Pollution | 18 | 2024 | 67 | 4.630 |
Why?
|
| Environmental Exposure | 22 | 2024 | 223 | 3.970 |
Why?
|
| Particulate Matter | 18 | 2024 | 69 | 3.710 |
Why?
|
| Maternal Exposure | 21 | 2022 | 147 | 3.690 |
Why?
|
| Occupational Exposure | 27 | 2022 | 129 | 3.580 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 64 | 3.390 |
Why?
|
| Metals, Heavy | 3 | 2021 | 18 | 1.990 |
Why?
|
| Texas | 36 | 2023 | 3590 | 1.940 |
Why?
|
| Stillbirth | 3 | 2019 | 81 | 1.860 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 75 | 1.720 |
Why?
|
| Industry | 10 | 2021 | 29 | 1.690 |
Why?
|
| Metals | 4 | 2023 | 62 | 1.690 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 49 | 1.520 |
Why?
|
| Arsenic | 4 | 2023 | 46 | 1.510 |
Why?
|
| Residence Characteristics | 6 | 2020 | 271 | 1.510 |
Why?
|
| Disasters | 3 | 2021 | 99 | 1.450 |
Why?
|
| Premature Birth | 5 | 2018 | 385 | 1.340 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 69 | 1.340 |
Why?
|
| Mexican Americans | 6 | 2018 | 204 | 1.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 230 | 1.320 |
Why?
|
| Ozone | 3 | 2019 | 18 | 1.250 |
Why?
|
| Stress, Psychological | 6 | 2021 | 561 | 1.190 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.170 |
Why?
|
| Pregnancy | 31 | 2024 | 7248 | 1.120 |
Why?
|
| Environmental Health | 3 | 2023 | 14 | 1.060 |
Why?
|
| Nitrogen Dioxide | 7 | 2024 | 17 | 0.930 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.870 |
Why?
|
| Soil Pollutants | 1 | 2021 | 9 | 0.780 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 67 | 0.770 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 9 | 0.760 |
Why?
|
| Deer | 1 | 2021 | 19 | 0.730 |
Why?
|
| Adult | 45 | 2023 | 29374 | 0.730 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 140 | 0.730 |
Why?
|
| Population Dynamics | 2 | 2019 | 31 | 0.720 |
Why?
|
| Disaster Planning | 1 | 2021 | 65 | 0.710 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 609 | 0.700 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 19 | 0.690 |
Why?
|
| Fires | 1 | 2020 | 12 | 0.680 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.670 |
Why?
|
| Humans | 97 | 2024 | 124311 | 0.660 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 17 | 0.650 |
Why?
|
| Pregnant Women | 1 | 2020 | 147 | 0.630 |
Why?
|
| Temperature | 1 | 2019 | 304 | 0.620 |
Why?
|
| Young Adult | 23 | 2023 | 8955 | 0.620 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 112 | 0.610 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.600 |
Why?
|
| Female | 65 | 2024 | 66312 | 0.600 |
Why?
|
| Logistic Models | 14 | 2019 | 1802 | 0.570 |
Why?
|
| Trace Elements | 1 | 2017 | 24 | 0.550 |
Why?
|
| Urban Population | 6 | 2019 | 226 | 0.540 |
Why?
|
| Butadienes | 1 | 2016 | 19 | 0.530 |
Why?
|
| Hazardous Substances | 5 | 2015 | 17 | 0.520 |
Why?
|
| Social Class | 2 | 2017 | 190 | 0.520 |
Why?
|
| Models, Statistical | 7 | 2024 | 472 | 0.510 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 565 | 0.500 |
Why?
|
| Leukemia | 1 | 2019 | 376 | 0.500 |
Why?
|
| Community Participation | 1 | 2015 | 44 | 0.490 |
Why?
|
| Multilingualism | 1 | 2015 | 44 | 0.490 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 36 | 0.480 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 3711 | 0.480 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 18 | 0.470 |
Why?
|
| Hypertension | 3 | 2018 | 1286 | 0.460 |
Why?
|
| Models, Theoretical | 7 | 2015 | 357 | 0.450 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3261 | 0.450 |
Why?
|
| Occupational Diseases | 6 | 2016 | 75 | 0.450 |
Why?
|
| Pilot Projects | 5 | 2020 | 1396 | 0.440 |
Why?
|
| Risk Assessment | 7 | 2021 | 3371 | 0.410 |
Why?
|
| Birth Certificates | 3 | 2019 | 14 | 0.400 |
Why?
|
| Cohort Studies | 12 | 2022 | 4729 | 0.390 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 53 | 0.380 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.370 |
Why?
|
| Water Supply | 2 | 2004 | 25 | 0.370 |
Why?
|
| Linear Models | 7 | 2017 | 671 | 0.370 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 870 | 0.370 |
Why?
|
| Infant, Newborn | 15 | 2024 | 8180 | 0.370 |
Why?
|
| Mercury | 2 | 2001 | 27 | 0.360 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 810 | 0.360 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 25 | 0.360 |
Why?
|
| Bayes Theorem | 7 | 2024 | 282 | 0.360 |
Why?
|
| Asthma | 7 | 2014 | 748 | 0.350 |
Why?
|
| Nickel | 2 | 2001 | 22 | 0.350 |
Why?
|
| Cities | 2 | 2020 | 47 | 0.340 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 4 | 0.330 |
Why?
|
| Particle Size | 4 | 2022 | 121 | 0.330 |
Why?
|
| Gestational Age | 5 | 2022 | 1162 | 0.320 |
Why?
|
| Odds Ratio | 10 | 2016 | 1247 | 0.320 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 75 | 0.320 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 321 | 0.320 |
Why?
|
| Disinfection | 2 | 2011 | 25 | 0.310 |
Why?
|
| Agriculture | 2 | 2006 | 29 | 0.310 |
Why?
|
| Pesticides | 3 | 2022 | 21 | 0.310 |
Why?
|
| Cognition Disorders | 1 | 2013 | 556 | 0.310 |
Why?
|
| Risk Factors | 17 | 2019 | 10124 | 0.310 |
Why?
|
| Male | 38 | 2023 | 60910 | 0.290 |
Why?
|
| Mining | 4 | 2010 | 8 | 0.280 |
Why?
|
| United States | 24 | 2019 | 10756 | 0.280 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.280 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.270 |
Why?
|
| Aerosols | 3 | 2022 | 65 | 0.260 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 16 | 0.260 |
Why?
|
| Biomarkers | 6 | 2017 | 2974 | 0.260 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 57 | 0.260 |
Why?
|
| Prevalence | 11 | 2018 | 2428 | 0.260 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.240 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1675 | 0.230 |
Why?
|
| Cleft Lip | 2 | 2017 | 124 | 0.230 |
Why?
|
| Cleft Palate | 2 | 2017 | 140 | 0.230 |
Why?
|
| Birth Weight | 5 | 2024 | 348 | 0.230 |
Why?
|
| SEER Program | 3 | 2014 | 198 | 0.230 |
Why?
|
| Trihalomethanes | 1 | 2004 | 2 | 0.230 |
Why?
|
| Risk | 3 | 2019 | 748 | 0.230 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 7 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2004 | 1174 | 0.210 |
Why?
|
| Data Collection | 4 | 2023 | 384 | 0.210 |
Why?
|
| Cobalt | 1 | 2022 | 17 | 0.200 |
Why?
|
| Tungsten | 1 | 2022 | 6 | 0.200 |
Why?
|
| Middle Aged | 20 | 2021 | 26384 | 0.200 |
Why?
|
| Health Surveys | 3 | 2020 | 243 | 0.200 |
Why?
|
| Child | 10 | 2024 | 24479 | 0.190 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.190 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.190 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 121 | 0.190 |
Why?
|
| Toluene | 3 | 2010 | 10 | 0.190 |
Why?
|
| Soil | 1 | 2021 | 55 | 0.190 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.190 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 19 | 0.190 |
Why?
|
| China | 1 | 2021 | 242 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 218 | 0.180 |
Why?
|
| Floods | 1 | 2021 | 14 | 0.180 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 9 | 0.180 |
Why?
|
| Exercise | 2 | 2017 | 819 | 0.180 |
Why?
|
| Women, Working | 2 | 2017 | 9 | 0.180 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 267 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 2870 | 0.170 |
Why?
|
| Food Contamination | 3 | 2007 | 23 | 0.170 |
Why?
|
| Cadmium | 1 | 2020 | 29 | 0.170 |
Why?
|
| Aged | 14 | 2021 | 19406 | 0.170 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.170 |
Why?
|
| Feasibility Studies | 4 | 2017 | 762 | 0.170 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 19 | 0.170 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.170 |
Why?
|
| Weather | 1 | 2019 | 11 | 0.170 |
Why?
|
| Regression Analysis | 5 | 2014 | 773 | 0.160 |
Why?
|
| Universities | 1 | 2020 | 126 | 0.160 |
Why?
|
| Urban Health | 1 | 2019 | 74 | 0.160 |
Why?
|
| Registries | 3 | 2019 | 1411 | 0.160 |
Why?
|
| RNA, Viral | 1 | 2021 | 538 | 0.160 |
Why?
|
| Child, Preschool | 8 | 2024 | 14052 | 0.160 |
Why?
|
| Adolescent | 13 | 2021 | 19310 | 0.160 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.160 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 18 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 182 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 312 | 0.150 |
Why?
|
| Drinking Behavior | 1 | 1998 | 8 | 0.150 |
Why?
|
| Analysis of Variance | 5 | 2001 | 1014 | 0.150 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 38 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2040 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 16 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2017 | 56 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1532 | 0.140 |
Why?
|
| Occupations | 1 | 2017 | 22 | 0.140 |
Why?
|
| Workplace | 2 | 2015 | 69 | 0.140 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 18 | 0.140 |
Why?
|
| Molecular Weight | 1 | 2017 | 392 | 0.130 |
Why?
|
| Fetal Development | 3 | 2022 | 131 | 0.130 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 351 | 0.130 |
Why?
|
| DNA Adducts | 1 | 1996 | 78 | 0.130 |
Why?
|
| Serum Albumin | 1 | 1996 | 109 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2016 | 7 | 0.130 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 16223 | 0.120 |
Why?
|
| Lead | 1 | 1995 | 23 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1146 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 28 | 0.120 |
Why?
|
| Papillomaviridae | 1 | 2016 | 139 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 33 | 0.120 |
Why?
|
| Menopause | 1 | 1995 | 75 | 0.120 |
Why?
|
| Cause of Death | 2 | 2014 | 467 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 6450 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 72 | 0.120 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3412 | 0.120 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 25 | 0.120 |
Why?
|
| Focus Groups | 1 | 2015 | 202 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 938 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 49 | 0.120 |
Why?
|
| Azithromycin | 1 | 2014 | 44 | 0.120 |
Why?
|
| Occupational Health | 3 | 2010 | 44 | 0.110 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 23 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 35 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 160 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 267 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 291 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 525 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 15 | 0.110 |
Why?
|
| North America | 3 | 2000 | 237 | 0.110 |
Why?
|
| Doxycycline | 1 | 2014 | 117 | 0.110 |
Why?
|
| Europe | 3 | 2000 | 353 | 0.110 |
Why?
|
| Smoking | 3 | 1996 | 1037 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 180 | 0.110 |
Why?
|
| Uncertainty | 1 | 2014 | 102 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1318 | 0.110 |
Why?
|
| Population Surveillance | 3 | 2012 | 389 | 0.100 |
Why?
|
| Poverty | 2 | 2015 | 419 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2015 | 131 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 8 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 12463 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 339 | 0.100 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 7 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 38 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 1888 | 0.100 |
Why?
|
| Iron, Dietary | 1 | 2012 | 16 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 288 | 0.100 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.090 |
Why?
|
| Health Personnel | 2 | 2006 | 504 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 43 | 0.090 |
Why?
|
| Gastroschisis | 1 | 2012 | 53 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 127 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 34158 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 38 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 507 | 0.090 |
Why?
|
| Age Factors | 4 | 2015 | 2812 | 0.090 |
Why?
|
| Demography | 3 | 2007 | 239 | 0.090 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.090 |
Why?
|
| Time Factors | 5 | 2001 | 6259 | 0.090 |
Why?
|
| Parity | 2 | 2007 | 79 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 3 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 382 | 0.080 |
Why?
|
| Research Design | 2 | 2007 | 688 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2014 | 815 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2022 | 6087 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5096 | 0.080 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1330 | 0.080 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 331 | 0.080 |
Why?
|
| Incidence | 4 | 2023 | 3080 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 737 | 0.070 |
Why?
|
| Japan | 2 | 1998 | 133 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 429 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 450 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2024 | 641 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2789 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 41 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 10 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 962 | 0.070 |
Why?
|
| Diet | 2 | 2011 | 1133 | 0.060 |
Why?
|
| Chlorine | 1 | 2004 | 14 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 424 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1414 | 0.060 |
Why?
|
| Disinfectants | 1 | 2004 | 25 | 0.060 |
Why?
|
| Water Purification | 1 | 2004 | 13 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2011 | 842 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 42 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2414 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1603 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 279 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 16 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 11 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 61 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 42 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 228 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 308 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 7 | 0.050 |
Why?
|
| Transients and Migrants | 1 | 2001 | 23 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 318 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 21 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2001 | 76 | 0.050 |
Why?
|
| Italy | 1 | 2001 | 113 | 0.050 |
Why?
|
| Sociological Factors | 1 | 2021 | 8 | 0.050 |
Why?
|
| Laboratories | 1 | 2022 | 83 | 0.050 |
Why?
|
| Medicaid | 2 | 2014 | 243 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1813 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 30 | 0.040 |
Why?
|
| Western Australia | 1 | 2000 | 4 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 481 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1554 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 401 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1268 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 20 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 20 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 16 | 0.040 |
Why?
|
| Menstruation | 1 | 2017 | 29 | 0.040 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 20 | 0.030 |
Why?
|
| Biotransformation | 1 | 1996 | 50 | 0.030 |
Why?
|
| Employment | 1 | 2017 | 67 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 765 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 89 | 0.030 |
Why?
|
| Time | 1 | 1996 | 94 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 235 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 131 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 70 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 180 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 59 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 24 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 149 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 152 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 125 | 0.030 |
Why?
|
| Income | 1 | 1995 | 133 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 41 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 656 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1241 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 383 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 260 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 52 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 48 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 245 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 65 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 376 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 53 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 68 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 443 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 354 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1599 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 9 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1479 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 86 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 59 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1317 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1416 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 374 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 410 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 816 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 473 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 519 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1509 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 786 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 292 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12278 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2018 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 766 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 478 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 176 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4256 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 37 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 192 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 406 | 0.000 |
Why?
|
| Models, Biological | 1 | 1993 | 1460 | 0.000 |
Why?
|